Management of Venous Thromboembolism in High-Grade Glioma: Does Low Molecular Weight Heparin Increase Intracranial Bleeding Risk?
Author
Jo, Jasmin; Donahue, Joseph; Sarai, Guneet; Petroni, Gina; Schiff, David
Date
2022
Citation:
APA:
Jo, Jasmin, & Donahue, Joseph, & Sarai, Guneet, & Petroni, Gina, & Schiff, David. (January 2022).
Management of Venous Thromboembolism in High-Grade Glioma: Does Low Molecular Weight Heparin Increase Intracranial Bleeding Risk?.
,
(),
-
. Retrieved from
http://hdl.handle.net/10342/12359
MLA:
Jo, Jasmin, and Donahue, Joseph, and Sarai, Guneet, and Petroni, Gina, and Schiff, David.
"Management of Venous Thromboembolism in High-Grade Glioma: Does Low Molecular Weight Heparin Increase Intracranial Bleeding Risk?". .
. (),
January 2022.
May 01, 2024.
http://hdl.handle.net/10342/12359.
Chicago:
Jo, Jasmin and Donahue, Joseph and Sarai, Guneet and Petroni, Gina and Schiff, David,
"Management of Venous Thromboembolism in High-Grade Glioma: Does Low Molecular Weight Heparin Increase Intracranial Bleeding Risk?," , no.
(January 2022),
http://hdl.handle.net/10342/12359 (accessed
May 01, 2024).
AMA:
Jo, Jasmin, Donahue, Joseph, Sarai, Guneet, Petroni, Gina, Schiff, David.
Management of Venous Thromboembolism in High-Grade Glioma: Does Low Molecular Weight Heparin Increase Intracranial Bleeding Risk?. .
January 2022;
():
.
http://hdl.handle.net/10342/12359. Accessed
May 01, 2024.
Collections